Projects funded by the NCN

Development of novel 1,3-selenazol-2-one derivatives incorporated into self-emulsifying drug delivery systems as a strat...

Call: OPUS 29 , Panel: NZ7

Principal investigator: dr hab. Robert Czarnomysy

Uniwersytet Medyczny w Białymstoku

The role of EZH2 activity in the development of resistance to targeted therapy in melanoma

Call: OPUS 28 , Panel: NZ7

Principal investigator: dr Michał Jerzy Woźniak

Uniwersytet Medyczny w Łodzi

A Fungal Hit Discovery Platform

Call: JPIAMR ACTION Call 2024 , Panel: NZ1

Principal investigator: dr Maria Magdalena Klimecka

Uniwersytet Warszawski

Disruption of the posttranslational activation of the translation factor EF-P as a new target for antimicrobial agents.

Call: OPUS 27 , Panel: NZ7

Principal investigator: dr Piotr Wilk

Uniwersytet Jagielloński

Development of novel screening method for identifying xanthine oxidase inhibitors – towards new drug candidates for gout...

Call: PRELUDIUM 23 , Panel: ST4

Principal investigator: Monika Katarzyna Rola

Politechnika Łódzka

A Compound Screening Platform for the Discovery of Histone- and Nucleosome-Targeting Agents

Call: OPUS 27 , Panel: NZ7

Principal investigator: prof. Curtis Davey

Uniwersytet Jagielloński

Development of technology for producing emulsions stabilized using biosurfactants dissolved in the oil phase. Increasing...

Call: OPUS 27 , Panel: ST8

Principal investigator: dr hab. Marcel Krzan

Instytut Katalizy i Fizykochemii Powierzchni im. Jerzego Habera PAN

Development and characterization of novel multitargeted organometallic tubulin polymerization inhibitors for enhancing t...

Call: OPUS 27 , Panel: NZ7

Principal investigator: dr hab. Damian Nestor Plażuk

Uniwersytet Łódzki

Semaglutide and neurodevelopment: investigating risks arising from prenatal exposure to a widely popular drug for diabet...

Call: OPUS 26 , Panel: NZ7

Principal investigator: dr Agnieszka Wnuk

Instytut Farmakologii PAN

Design and Development of Serine Hydroxymethyltransferase-2 (SHMT2) Inhibitors Blocking Tumor Growth

Call: SONATA BIS 13 , Panel: NZ7

Principal investigator: dr hab. Miłosz Ruszkowski

Instytut Chemii Bioorganicznej PAN

Development of bioresorbable polymer materials for the personalized ureteralstents releasing the antispasmodic drug

Call: OPUS 25 , Panel: ST11

Principal investigator: prof. Janusz Edward Kasperczyk

Centrum Materiałów Polimerowych i Węglowych PAN

Three-phase drug carriers - design towards a prolonged release, development of a transport model and its verification. C...

Call: PRELUDIUM BIS 4 , Panel: ST8

Principal investigator: prof. Anna Trusek

Politechnika Wrocławska

Search for Inhibitors of Human δ1-Pyrroline-5-Carboxylate Reductase 1 (PYCR1) as Lead Molecules for the Development of N...

Call: OPUS 22 , Panel: NZ7

Principal investigator: dr hab. Miłosz Ruszkowski

Instytut Chemii Bioorganicznej PAN

Nanospectroscopic imaging of native biological membranes: Is the cell membrane the key for understanding the mechanism o...

Call: SONATA BIS 11 , Panel: ST4

Principal investigator: dr Katarzyna Pogoda

Instytut Fizyki Jądrowej im. Henryka Niewodniczańskiego PAN

Development of new implantable drug forms, biodegradable nanofibers containing selected betulin derivatives in order to ...

Call: OPUS 21 , Panel: NZ7

Principal investigator: prof. Janusz Edward Kasperczyk

Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Farmaceutycznych w Sosnowcu

Development of tools for the rational design of peptide therapeutics

Call: OPUS 20 , Panel: NZ2

Principal investigator: dr hab. Sebastian Kmiecik

Uniwersytet Warszawski, Centrum Nauk Biologiczno-Chemicznych

Development of an in vitro model for the evaluation of phototoxicity of drugs with different affinity to melanin using a...

Call: SONATA 16 , Panel: NZ7

Principal investigator: dr hab. Jakub Rok

Śląski Uniwersytet Medyczny w Katowicach, Wydział Nauk Farmaceutycznych w Sosnowcu

Isotope labelled ferritin - development of an alternative drug delivery system

Call: PRELUDIUM 18 , Panel: ST4

Principal investigator: Łukasz Cheda

Uniwersytet Warszawski, Wydział Chemii

DEVELOPMENT OF NEW CLASS PHOTOACTIVATED ANTICANCER-ANTIFUNGAL COMPOUNDS: CONJUGATES OF GOLD NANOPARTICLE-SUPPORTED QUINO...

Call: OPUS 17 , Panel: NZ7

Principal investigator: dr hab. Oleh M. Demchuk

Katolicki Uniwersytet Lubelski Jana Pawła II, Wydział Medyczny

Development of a comprehensive set of computational tools for the search of new ligands of particular receptor - case st...

Call: OPUS 16 , Panel: NZ2

Principal investigator: dr hab. Sabina Marta Podlewska

Instytut Farmakologii PAN

Molecular picture of the mechanochemical coupling in ATP synthase as a conceptual framework for the development of novel...

Call: SONATA BIS 7 , Panel: NZ2

Principal investigator: dr hab. Jacek Czub

Politechnika Gdańska, Wydział Chemiczny

Exosome biosensors - new tools in cancer screening, diagnostics and development of targeted drug delivery system

Call: OPUS 13 , Panel: ST4

Principal investigator: dr hab. Magdalena Stobiecka

Szkoła Główna Gospodarstwa Wiejskiego w Warszawie, Instytut Biologii

Development of protocol for in silico design of compounds inhibit Ebola virus infection

Call: PRELUDIUM 11 , Panel: NZ2

Principal investigator: Dawid Zdzisław Warszycki

Instytut Farmakologii PAN

Dissecting mechanisms of RNA-based Stress Granules formation, their structure and role in the development of Multi-Drug ...

Call: OPUS 9 , Panel: NZ7

Principal investigator: dr hab. Witold Szaflarski

Uniwersytet Medyczny im. Karola Marcinkowskiego w Poznaniu, Wydział Medyczny

Development of optimization methods for dose selection of analgesic drugs used as a combination drug therapy in neuropat...

Call: OPUS 9 , Panel: NZ7

Principal investigator: dr hab. Kinga Sałat

Uniwersytet Jagielloński- Collegium Medicum, Uniwersytet Jagielloński - Collegium Medicum; Wydział Farmaceutyczny

Development of new strategies for synthesis of inorganic-organic porous materials

Call: SONATA BIS 4 , Panel: ST5

Principal investigator: dr Wojciech Bury

Uniwersytet Wrocławski, Wydział Chemii

Molecular mechanism for the effects of stress hormones on development of drug addiction

Call: MAESTRO 4 , Panel: NZ3

Principal investigator: prof. Ryszard Przewłocki

Instytut Farmakologii PAN

Development of a method for the structure prediction of GPCRs complexes with agonists and antagonists, including the lig...

Call: SONATA 1 , Panel: NZ2

Principal investigator: dr Michał Koliński

Instytut Medycyny Doświadczalnej i Klinicznej im. Mirosława Mossakowskiego PAN

Novel, chemometrically assisted, metabolic based research strategy in anticancer drug development on the example of benz...

Call: PRELUDIUM 1 , Panel: NZ1

Principal investigator: Mariusz Marcin Belka

Gdański Uniwersytet Medyczny, Wydział Faramcautyczny z Oddziałem Medycyny Laboratoryjnej